Unleashing T cell anti-tumor immunity: new potential for 5-Nonloxytryptamine as an agent mediating MHC-I upregulation in tumors.
Stachura P, Liu W, Xu HC, Wlodarczyk A, Stencel O, Pandey P, Vogt M, Bhatia S, Picard D, Remke M, Lang KS, Häussinger D, Homey B, Lang PA, Borkhardt A, Pandyra AA.
Stachura P, et al. Among authors: lang ks.
Mol Cancer. 2023 Aug 15;22(1):136. doi: 10.1186/s12943-023-01833-8.
Mol Cancer. 2023.
PMID: 37582744
Free PMC article.